LAVA Therapeutics N.V.

LVTX · NASDAQ
Analyze with AI
Filings26
Total reported value$18.0M
ManagerSharesValue
Change
Shay Capital LLC2.5M$4.4M+50.0%
Redmile Group, LLC2.1M$3.6M0.0%
BML Capital Management, LLC2M$3.4M0.0%
Sanofi1.9M$3.3M0.0%
Merck & Co., Inc.1.1M$2.0M0.0%
GTS SECURITIES LLC200K$348.0K+50.0%
Rangeley Capital, LLC165K$287.1K+45.5%
PNC FINANCIAL SERVICES GROUP, INC.65K$113.1K0.0%
CITADEL ADVISORS LLC53.3K$92.8K+2.7%
ROYAL BANK OF CANADA44.3K$77.2K+50.0%
Lepercq De Neuflize Asset Management LLC31K$53.9K0.0%
JBF Capital, Inc.23.9K$41.6K+50.0%
XTX Topco Ltd21.7K$37.8K+50.0%
UBS Group AG15.9K$27.6K-3.3%
TORNO CAPITAL, LLC15K$26.1K+50.0%
GEODE CAPITAL MANAGEMENT, LLC14.2K$24.7K0.0%
EQUITEC PROPRIETARY MARKETS, LLC12.5K$21.8K+50.0%
JONES FINANCIAL COMPANIES LLLP400$696.00.0%
TSFG, LLC400$696.00.0%
SBI Securities Co., Ltd.300$522.00.0%
Smallwood Wealth Investment Management, LLC26$45.2+50.0%
BNP PARIBAS ARBITRAGE, SNC0$0.0+100.0%
Pathway Financial Advisors LLC0$0.0+100.0%
TWO SIGMA INVESTMENTS, LP0$0.0+100.0%
Bruce & Co., Inc.0$0.0+100.0%
TWO SIGMA SECURITIES, LLC0$0.0+100.0%